47 related articles for article (PubMed ID: 10989731)
1. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
Gómez-Acebo I; Dierssen-Sotos T; Palazuelos C; Pérez-Gómez B; Lope V; Tusquets I; Alonso MH; Moreno V; Amiano P; Molina de la Torre AJ; Barricarte A; Tardon A; Camacho A; Peiro-Perez R; Marcos-Gragera R; Muñoz M; Michelena-Echeveste MJ; Ortega Valin L; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
PLoS One; 2016; 11(8):e0159672. PubMed ID: 27508297
[TBL] [Abstract][Full Text] [Related]
2. Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study.
Krämer HU; Raum E; Rüter G; Schöttker B; Rothenbacher D; Rosemann T; Szecsenyi J; Brenner H
Cardiovasc Diabetol; 2012 Jul; 11():88. PubMed ID: 22838970
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular medication use and risk for colorectal cancer.
Boudreau DM; Koehler E; Rulyak SJ; Haneuse S; Harrison R; Mandelson MT
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3076-80. PubMed ID: 18957524
[TBL] [Abstract][Full Text] [Related]
4. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.
Sørensen HT; Mellemkjaer L; Olsen JH
Br J Clin Pharmacol; 2001 Sep; 52(3):313-8. PubMed ID: 11560564
[TBL] [Abstract][Full Text] [Related]
5. Correlation between Sex and Prognosis of Acute Aortic Dissection in the Chinese Population.
Liu YJ; Wang XZ; Wang Y; He RX; Yang L; Jing QM; Liu HW
Chin Med J (Engl); 2018 Jun; 131(12):1430-1435. PubMed ID: 29893359
[TBL] [Abstract][Full Text] [Related]
6. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study.
Lindberg G; Bingefors K; Ranstam J; Råstam L; Melander A
BMJ; 1998 Mar; 316(7133):741-5. PubMed ID: 9529409
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Satisfaction with Drug Provision of Antihypertensive Drugs at the Outpatient Level of Privileged Categories of Residens.
Jamil A; Sundetgali K; Laura S; Ainur T; Daniyar T; Sabit P; Kanatzhan K
Int J Prev Med; 2022; 13():69. PubMed ID: 35706885
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach.
Hajian-Tilaki KO; Heidari B
Obes Rev; 2007 Jan; 8(1):3-10. PubMed ID: 17212790
[TBL] [Abstract][Full Text] [Related]
9. [Quality of life and antihypertensive therapy].
Vajó Z; Székács B
Orv Hetil; 1993 Nov; 134(45):2477-9. PubMed ID: 7902554
[TBL] [Abstract][Full Text] [Related]
10. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
[TBL] [Abstract][Full Text] [Related]
11. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
12. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
13. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
[TBL] [Abstract][Full Text] [Related]
14. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
Rejnmark L; Vestergaard P; Mosekilde L
J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
